Future studies will utilize whole-genome approaches to identify transcriptional targets of LMO4 in the BLC, which may not only illuminate the mechanism by which LMO4 regulates fear learning, but also identify potential therapeutic candidates for treating cognitive impairments associated with a variety of neurological disorders. The gene discussed is LMO4; the disease is nervous system disorder.